Back
Ares Management 10K Form
Buy
70
ARES
Ares Management
Last Price:
130.65
Seasonality Move:
6.93%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-06 | 10Q | ARES/Ares Management Quarterly |
| 2023-08-03 | 10Q | ARES/Ares Management Quarterly |
| 2023-05-08 | 10Q | ARES/Ares Management Quarterly |
| 2022-11-07 | 10Q | ARES/Ares Management Quarterly |
| 2022-08-05 | 10Q | ARES/Ares Management Quarterly |
| 2022-05-09 | 10Q | ARES/Ares Management Quarterly |
Receive ARES News And Ratings
See the #1 stock for the next 7 days that we like better than ARES
ARES Financial Statistics
Sales & Book Value
| Annual Sales: | $4.99B |
|---|---|
| Cash Flow: | $-583.06M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $9.94 |
| Price / Book: | 13.35 |
Profitability
| EPS (TTM): | 2.39000 |
|---|---|
| Net Income (TTM): | $474.33M |
| Gross Margin: | $3.5B |
| Return on Equity: | 11.65% |
| Return on Assets: | 2.06% |
Ares Management Earnings Forecast
Key Ares Management Financial Ratios
- The Gross Profit Margin over the past 13 years for ARES is 70.19%.
- The Selling, General & Administrative Expenses for ARES have been equal to 25.42% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 181.49% of Operating Income.
- The Net Earning history of ARES is 9.51% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 5 years.
Ares Management Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Capital Markets |
| Sector: | Financials |
| Current Symbol: | ARES |
| CUSIP: | 03990B |
| Website: | aresmgmt.com |
Debt
| Debt-to-Equity Ratio: | 8.15 |
|---|---|
| Current Ratio: | 0.73 |
| Quick Ratio: | 0.73 |
Price-to-Earnings
| Trailing P/E Ratio: | 54.01 |
|---|---|
| Forward P/E Ratio: | 21.3 |
ARES Technical Analysis vs Fundamental Analysis
Buy
70
Ares Management (ARES)
is a Buy
Is Ares Management a Buy or a Sell?
-
Ares Management stock is rated a Buy
The current Ares Management [ARES] share price is $130.70. The Score for ARES is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.